SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 524 filers reported holding SEAGEN INC in Q4 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $221,305,263 | -16.3% | 1,043,155 | -24.0% | 0.02% | -13.6% |
| Q2 2023 | $264,334,205 | -54.6% | 1,373,450 | -52.2% | 0.02% | -18.5% |
| Q1 2023 | $582,037,840 | +62.2% | 2,874,686 | +2.9% | 0.03% | -25.0% |
| Q4 2022 | $358,944,495 | +2.5% | 2,793,125 | +9.2% | 0.04% | -2.7% |
| Q3 2022 | $350,095,000 | -25.9% | 2,558,603 | -4.2% | 0.04% | -21.3% |
| Q2 2022 | $472,730,000 | +44.8% | 2,671,697 | +17.9% | 0.05% | +80.8% |
| Q1 2022 | $326,433,000 | +64.8% | 2,266,104 | +76.9% | 0.03% | +73.3% |
| Q4 2021 | $198,020,000 | -13.6% | 1,280,857 | -5.1% | 0.02% | -16.7% |
| Q3 2021 | $229,195,000 | +65.0% | 1,349,799 | +53.4% | 0.02% | +63.6% |
| Q2 2021 | $138,915,000 | +116.7% | 879,877 | +90.6% | 0.01% | +120.0% |
| Q1 2021 | $64,102,000 | -83.1% | 461,630 | -78.6% | 0.01% | -85.3% |
| Q4 2020 | $378,430,000 | – | 2,160,731 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $8,300,656,000 | 47.09% |
| Eagle Health Investments LP | 262,502 | $46,447,000 | 10.83% |
| EcoR1 Capital, LLC | 1,008,628 | $178,467,000 | 6.16% |
| Lagoda Investment Management, L.P. | 49,460 | $8,751,000 | 5.80% |
| Redmile Group, LLC | 854,013 | $151,109,000 | 5.77% |
| Nan Fung Group Holdings Ltd | 47,096 | $8,333,000 | 5.72% |
| Atika Capital Management LLC | 282,500 | $49,985,000 | 5.62% |
| Avoro Capital Advisors LLC | 1,525,000 | $269,834,000 | 5.33% |
| Parkman Healthcare Partners LLC | 76,626 | $13,558,000 | 4.99% |
| Artal Group S.A. | 525,000 | $92,894,000 | 4.96% |